QA: Amicus Therapeutics INC in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178879_2022_Amicus_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001178879, Amicus Therapeutics INC

  xvar xval
0 AssetsCurrent 596,834,000
1 IntangibleAssetsNetIncludingGoodwill 220,797,000
2 PropertyPlantAndEquipmentNet 42,496,000
3 remainder_Assets 45,013,000
4 LiabilitiesCurrent 145,975,000
5 LiabilitiesNoncurrent 50,164,000
6 remainder_Liabilities 401,632,000
7 CostOfGoodsAndServicesSold 39,216,482
8 SellingGeneralAndAdministrativeExpense 219,611,382
9 ResearchAndDevelopmentExpense 246,870,818
10 remainder_Expenses 49,071,681
11 remainder_Revenues 310,806,584
12 remainder_NetIncome -3,304,189
13 remainder_ComprehensiveNetIncome 1,782,613
  yvar yval
0 Assets 905,140,000
1 Liabilities 597,771,000
2 Expenses 554,770,363
3 Revenues 310,806,584
4 StockholdersEquity 307,369,000
5 NetIncome -247,267,968
6 ComprehensiveNetIncome -246,376,662
7 BaseVar 1,186,787,374
8 EconomicCapitalRatiobeforeLimitedLiability 0.564
9 EconomicCapitalRatio 1.94

Edgar->Model Mapping

Feature Distribution

Change over Time